We are monitoring the impact of COVID-19 on North America IVD Market Get in touch with us for detailed analysis Know More
Pulished Date August, 2019
ID: 122
Share on
Share on

North America In-Vitro Diagnostics Market Research Report - Segmented By Product, By Technology, By Application & By Country (United States, Canada, Mexico & Rest of North America) - Industry Analysis, Size, Share, Growth, Trends, & Forecast | 2019 - 2024

Pulished: August, 2019
ID: 122
Pages: 145

North America In-Vitro Diagnostics (IVD) Market Size & Growth (2019 to 2024)

The size of North American IVD Market has been estimated at USD 25.9 billion in 2019 and is expected to reach 32.59 billion in 2024 at a Compound Annual Growth Rate (CAGR) of 4.7%, as per the recently published report of Market Data Forecast. Within North America, the United States IVD Market expected to occupy the majority of the shares.

Growing prevalence for early diagnosis of diseases, increasing incidences of infectious and chronic diseases and adoption of point-of-care testing devices for the accurate results in very less time are majorly driving the growth of the North American In-Vitro Diagnostics Market. The trend towards personalized medicines, rise in the investments on hospitals and clinics by government and non-government organizations and growth in the scale of diagnostic centres along with the increasing flow of patients are expected to fuel the North American IVD market.

The adoption of the latest technologies and the launch of innovative products in favour of the end-users in the medical sector is certainly to create growth opportunities for the market. Along with this, rising awareness over the availability of different treatment procedures for various diseases among individuals and on-going research on the development of new devices in concern towards people’s safety and adequate support from the private sectors through investments are lavishing the demand of the market in North America.

However, the high cost for installation and maintenance of the equipment used in the diagnostic centres is quietly restricting the demand of the in-vitro diagnostics market in North America. Lack of standardization is one more factor hindering the growth rate of the market. The dearth of skilled people in operating the devices more accurately and analyzing the reports has remained a challenging factor for the market players. Frequent changes in the economic strategies may also impact negatively on the growth rate of the market in North America.

The U.S. In-Vitro Diagnostics Market

The United States has the largest In-Vitro diagnostics market in the world. The continuous awareness and product innovations are the factors behind the leading market. In the United States section 210 of the Federal Food, Drug and cosmetic act says that the diagnostics products are medical devices and also the biological product subject.  

The use of point-of-care (POC) diagnostics, high occurrence of chronic diseases, heart diseases, asthma, diabetes and the Covid-19 in 2020 are majorly boosting up the demand of the market. These diseases are responsible for the high mortality rate in the United States. The use of In-vitro diagnostics is feasible in managing chronic conditions. Advances in DNA sequencing, growing demand of the diagnostic devices, customers healthcare spending and government funds will increase the business of U.S. In-Vitro Diagnostics Market in the forecast period. 

This research report segmented and sub-segmented into the following categories:

  • By Product: Instruments, Reagents, Kits, Software
  • By Technology: Clinical Chemistry, Hematology, Immunoassays, Coagulation and Hemostasis, Molecular Diagnostics, Microbiology & Other IVD technologies
  • By Application: Diabetes, Infectious, Oncology/Cancer, Cardiology, Nephrology, Autoimmune Diseases, Drug Testing, HIV
  • By Country: US, Canada, Mexico, Rest of North America

On the basis of geography, North America is the largest market accounting for a share of around 37% in the global IVD market owing to the growing prevalence of chronic diseases such as cancer and respiratory diseases Within North America, United States is the largest market for In-Vitro diagnostics accounting for a share of XX% while Canada is estimated to be the fastest-growing with a healthy CAGR.

Companies holding the majority of the shares in the North American IVD Market profiled in the report are Abbott Laboratories, Johnson and Johnson, Siemens Healthcare, Becton Dickinson, Roche Diagnostic, Beckman Coulter Inc., Biomérieux, Ortho Clinical Diagnostics, Inc., Bio-Rad Laboratories, Inc., Danaher Corporation, Sysmex Corporation & Thermo Fisher Scientific, Inc.

  1. Introduction

                1.1 Market Definition                                                                    

                1.2 Study Deliverables                                                                  

                1.3 Base Currency, Base Year and Forecast Periods                                                                           

                1.4 General Study Assumptions                                                                

  1. Research Methodology

                2.1 Introduction                                                                              

                2.2 Research Phases                                                                      

                                2.2.1 Secondary Research                                                            

                                2.2.2 Primary Research                                                 

                                2.2.3 Econometric Modelling                                                     

                                2.2.4 Expert Validation                                                  

                2.3 Analysis Design                                                                         

                2.4 Study Timeline                                                                          

  1. Overview

                3.1 Executive Summary                                                                

                3.2 Key Inferences                                                                         

                3.3 New Developments                                                                

  1. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)

                4.1 Market Drivers                                                                          

                4.2 Market Restraints                                                                    

                4.3 Key Challenges                                                                         

                4.4 Current Opportunities in the Market                                                               

  1. Market Segmentation

                5.1 By Product                                                                  

                                5.1.1 Instruments                                                           

                                5.1.2 Reagents and Kits                                                 

                                5.1.3 Software                                                 

                5.2 By Technology                                                                          

                                5.2.1 Clinical Chemistry                                                

                                5.2.2 Hematology                                                           

                                5.2.3 Immunoassays                                                      

                                5.2.4 Coagulation and Hemostasis                                                           

                                5.2.5 Molecular Diagnostics                                                        

                                5.2.6 Microbiology                                                          

                                5.2.7 Other IVD technologies                                                     

                5.3 By Application                                                                           

                                5.3.1 Diabetes                                                  

                                5.3.2 Infectious Diseases                                                             

                                5.3.3 Oncology/Cancer                                                 

                                5.3.4 Cardiology                                                               

                                5.3.5 Nephrology                                                            

                                5.3.6 Autoimmune Diseases                                                       

                                5.3.7 Drug Testing                                                           

                                5.3.8 HIV                                                             

  1. Geographical Analysis

                                6.1 Introduction                                                              

                                6.2 United States                                                            

                                6.3 Canada                                                         

  1. Strategic Analysis

                7.1 PESTLE analysis                                                                         

                                7.1.1 Political                                                     

                                7.1.2 Economic                                                 

                                7.1.3 Social                                                         

                                7.1.4 Technological                                                         

                                7.1.5 Legal                                                          

                                7.1.6 Environmental                                                      

                7.2 Porter’s Five analysis                                                                              

                                7.2.1 Bargaining Power of Suppliers                                                        

                                7.2.2 Bargaining Power of Consumers                                                    

                                7.2.3 Threat of New Entrants                                                     

                                7.2.4 Threat of Substitute Products and Services                                               

                                7.2.5 Competitive Rivalry within the Industry                                                      

  1. Market Leaders' Analysis

                8.1 Abbott Laboratories                                                               

                                8.1.1 Overview                                                

                                8.1.2 Product Analysis                                                   

                                8.1.3 Strategic Evaluation and Operations                                                            

                                8.1.4 Financial analysis                                                  

                                8.1.5 Legal issues                                                            

                                8.1.6 Recent Developments                                                       

                                8.1.7 SWOT analysis                                                       

                                8.1.8 Analyst View                                                          

                8.2 Johnson and Johnson                                                                             

                8.3 Siemens Healthcare                                                                

                8.4 Becton Dickinson                                                                     

                8.5 Roche Diagnostics                                                                    

                8.6 Beckman Coulter Inc.                                                                             

                8.7 Biomérieux                                                                

                8.8 Ortho Clinical Diagnostics, Inc.                                                                           

                8.9 Bio-Rad Laboratories, Inc.                                                                    

                8.10 Danaher Corporation                                                                           

                8.11 Sysmex Corporation                                                                             

                8.12 Thermo Fisher Scientific, Inc.                                                                            

  1. Competitive Landscape

                9.1 Market share analysis                                                                            

                9.2 Merger and Acquisition Analysis                                                                        

                9.3 Agreements, collaborations and Joint Ventures                                                                          

                9.4 New Product Launches                                                                          

  1. Expert Opinions

                10.1 Market Outlook                                                                     

                10.2 Investment Opportunities                                                                 

     Appendix                                                                                           

  1. List of Tables
  2. List of Figures
  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
  1. North America Global In-Vitro Diagnostics market By Region, From 2019-2024 ( USD Billion )                                                        
  2. North America Global In-Vitro Diagnostics market By Type, From 2019-2024 ( USD Billion )                                                            
  3. North America Instruments Market By Region, From 2019-2024 ( USD Billion )                                                    
  4. North America Reagents and Kits Market By Region, From 2019-2024 ( USD Billion )                                                         
  5. North America Software Market By Region, From 2019-2024 ( USD Billion )                                                           
  6. North America Clinical Chemistry Market By Region, From 2019-2024 ( USD Billion )                                                         
  7. North America Hematology Market By Region, From 2019-2024 ( USD Billion )                                                    
  8. North America Immunoassays Market By Region, From 2019-2024 ( USD Billion )                                               
  9. North America Coagulation and Hemostasis Market By Region, From 2019-2024 ( USD Billion )                                                    
  10. North America Molecular Diagnostics Market By Region, From 2019-2024 ( USD Billion )                                                 
  11. North America Microbiology Market By Region, From 2019-2024 ( USD Billion )                                                  
  12. North America Other IVD technologies Market By Region, From 2019-2024 ( USD Billion )                                                              
  13. North America Diabetes Market By Region, From 2019-2024 ( USD Billion )                                                           
  14. North America Infectious Diseases Market By Region, From 2019-2024 ( USD Billion )                                                       
  15. North America Oncology/Cancer Market By Region, From 2019-2024 ( USD Billion )                                                          
  16. North America Cardiology Market By Region, From 2019-2024 ( USD Billion )                                                       
  17. North America Nephrology Market By Region, From 2019-2024 ( USD Billion )                                                     
  18. North America Autoimmune Diseases Market By Region, From 2019-2024 ( USD Billion )                                                
  19. North America Drug Testing Market By Region, From 2019-2024 ( USD Billion )                                                    
  20. North America HIV Market By Region, From 2019-2024 ( USD Billion )                                                      
  21. United States Market By Product, From 2019-2024 ( USD Billion )                                                              
  22. United States Market By Technology, From 2019-2024 ( USD Billion )                                                       
  23. United States Market By Application, From 2019-2024 ( USD Billion )                                                       
  24. Canada Market By Product, From 2019-2024 ( USD Billion )                                                          
  25. Canada Market By Technology, From 2019-2024 ( USD Billion )                                                   
  26. Canada Market By Application, From 2019-2024 ( USD Billion )                                                   

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 3335

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample